Weight loss and weight loss maintenance efficacy of a novel weight loss program: The retrospective RNPC® cohort
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Weight loss and weight loss maintenance efficacy of a novel weight loss program: The retrospective RNPC® cohort. / Thorning, Tanja Kongerslev; Fabre, Odile; Legrand, Rémy; Astrup, Arne; Hjorth, Mads Fiil.
I: Obesity Medicine, Bind 10, 2018, s. 16-23.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Weight loss and weight loss maintenance efficacy of a novel weight loss program: The retrospective RNPC® cohort
AU - Thorning, Tanja Kongerslev
AU - Fabre, Odile
AU - Legrand, Rémy
AU - Astrup, Arne
AU - Hjorth, Mads Fiil
N1 - CURIS 2018 NEXS 168
PY - 2018
Y1 - 2018
N2 - Objective: Bodyweight loss is essential to lower risk factors for type 2 diabetes and cardiovascular disease in overweight patients. Therefore, we examined the effectiveness of the RNPC® program for short and long term bodyweight reduction.Methods: The RNPC® program is a novel weight loss and maintenance program achieving weight loss by an energy-restricted 800–1000 kcal/day high-protein low-glycemic diet (weight loss phase), followed by an intensive follow-up with a step-wise increase in energy intake to reach energy balance (weight stabilizationphases). The analysis included 12,179 overweight or obese patients treated in 54 RNPC® weight loss clinics in France.Results: A total of 10,809 (89%) patients completed the initial weight loss phase and 2996 (25%) completed the full program. Median weight loss percentage was 10.7% (Interquartile range [IQR]: 5.8; 16.5) after a median of 105 days (IQR: 56; 175) during the weight loss phase, and a median of 17.5% (IQR: 12.7; 24.2) after a median of 251 days (IQR: 187; 350) at program completion.Conclusion: The RNPC® program is cost-effective and well tolerated for short-term body weight loss as well as effective in the long term among the patients completing the program. The program might be particularly effective among patient with elevated fasting glucose.
AB - Objective: Bodyweight loss is essential to lower risk factors for type 2 diabetes and cardiovascular disease in overweight patients. Therefore, we examined the effectiveness of the RNPC® program for short and long term bodyweight reduction.Methods: The RNPC® program is a novel weight loss and maintenance program achieving weight loss by an energy-restricted 800–1000 kcal/day high-protein low-glycemic diet (weight loss phase), followed by an intensive follow-up with a step-wise increase in energy intake to reach energy balance (weight stabilizationphases). The analysis included 12,179 overweight or obese patients treated in 54 RNPC® weight loss clinics in France.Results: A total of 10,809 (89%) patients completed the initial weight loss phase and 2996 (25%) completed the full program. Median weight loss percentage was 10.7% (Interquartile range [IQR]: 5.8; 16.5) after a median of 105 days (IQR: 56; 175) during the weight loss phase, and a median of 17.5% (IQR: 12.7; 24.2) after a median of 251 days (IQR: 187; 350) at program completion.Conclusion: The RNPC® program is cost-effective and well tolerated for short-term body weight loss as well as effective in the long term among the patients completing the program. The program might be particularly effective among patient with elevated fasting glucose.
KW - Faculty of Science
KW - Overweight
KW - Obesity
KW - Protein
KW - Weight loss
KW - Weight maintenance
KW - Diet
U2 - 10.1016/j.obmed.2018.05.001
DO - 10.1016/j.obmed.2018.05.001
M3 - Journal article
VL - 10
SP - 16
EP - 23
JO - Obesity Medicine
JF - Obesity Medicine
SN - 2451-8476
ER -
ID: 196404293